Clinical Use of Thromboelastography as Monitor of Coagulopathy at the Pre and Post-Cardiopulmonary Bypass.
- Author:
Kyung Hoon KANG
1
;
Kyoung Hoon KIM
;
Yong HUR
;
Byung Yul KIM
;
Jung Ho LEE
Author Information
1. Department of Thoracic and Cardiovascular Surgery, National Medical Center, Korea.
- Publication Type:Original Article
- Keywords:
Thromboelastography, Coagulation
- MeSH:
Cardiopulmonary Bypass;
Fibrin;
Hemorrhage;
Hemostasis;
Platelet Aggregation;
Platelet Count;
Thoracic Surgery;
Thrombelastography*
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1997;30(11):1092-1096
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Thromboelastography(TEG) enables a global assessment of hemostatic function to be made from a single blood sample, documenting the interaction of platelets with protein coagulation cascade from the time of the initial platelet-fibrin interaction, through platelet aggregation, clot strengthening and fibrin cross linking to eventual clot lysis. Thirty-five patients(mean age 34+/-12) undergoing open heart surgery from April 1st, 1996 to August 31th, 1996 were investigated at preoperatively and immediate, one hour, and 24 hours after cessation of cardiopulmonary bypass using TEG. Comparisons were made between classic hematological indices and TEG data. There were statistically significant correlation between maximal amplitude(MA) and platelet count before CPB, activating clotting time(ACT) and TEG date(R time, K time and a angle) at 24-hour after CPB. The data on the predictive accuracy for postoperative bleeding at 24-hour after CPB, the TEG was significantly better than ACT(57%) or the coagulation profiles(43%) as a predictor of postoperative bleeding, with an accuracy rate of 100%(P=0.0043). In conclusion, TEG seems to be easy to use, clinically accurate, cost effective and provides data which can effectively manage a patient's hemostasis.
